While a predominant body of studies underscores that adiponectin levels tend to be diminished in psoriasis sufferers relative to those in good health, the implications could be an enhancement of the pronouncedness of cutaneous manifestations (72, 73). This evidence concerns the gene ADIPOQ and psoriasis.